A new fungal immunomodulatory protein (Fip) has been purified from the edible mushroom, Vol ariella ol acea, and designated Fip-o. Analysis of the purified protein by SDS\PAGE followed by Coomassie Blue staining demonstrated that Fip-o is a single polypeptide with an apparent molecular mass of 15 kDa. Periodic acid\Schiff staining showed that this single polypeptide lacks carbohydrates. Using an in itro bioassay measuring blastformation stimulatory activity, Fip-o was shown to stimulate the maximum proliferation of human peripheral blood lymphocytes at a concentration of 5 µg\ml. Fip-o was capable of agglutinating rat red blood cells. Neither haemagglutination nor mitogenic activities were inhibited by mono-or dimeric sugars. In i o, repeat administration of Fip-o greatly reduced the production of BSA-induced Arthus reaction in mice, whereas
INTRODUCTION
Modulation of the immune system by various agents may have potential for the management of certain infections, autoimmune diseases, graft rejection, as well as neoplastic diseases. Many proteins purified from plant seeds, for example concanavalin A, phytohaemagglutinin (PHA), wheat germ agglutinin and pokeweed mitogen, bind to specific carbohydrate residues on the lymphocyte membrane and induce a cascade of events leading to cell activation, including proliferation, production of lymphokines and differentiation. A group of fungal proteins defined by amino acid sequence similarity and their actions on immunological responses are classified into a distinct family, fungal immunomodulatory protein (Fip) [1, 2] . The molecular masses of Fips were estimated to be approx. 15 kDa by SDS\PAGE and their major biological activities resembled the mitogenic activity of lectins towards mouse spleen cells and human peripheral blood lymphocytes (PBL). LZ-8, a well characterized Fip isolated from the mycelia of Ganoderma lucidium [1] , showed the optimal blast-formation stimulatory activity towards mouse spleen cells at a concentration of 3.13 µg\ml, while another Fip, Fip-f e, isolated from the fruit bodies of Flammulina elutipes [2] , stimulated the maximum proliferation of human PBL at 100 µg\ml. Fips showed various degrees of haemagglutination activity of the red blood cells of different species. Fip-f e was able to agglutinate human red blood cells, whereas LZ-8 exerted its haemagglutination activity on sheep red blood cells. No aggregation was observed between human red blood cells in the presence of LZ-8.
The immunomodulatory activities of Fips were explored by
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little effect was observed on the prevention of systemic anaphylaxis reactions. The selectively enhanced transcriptional expression of interleukin (IL)-2, IL-4, interferon-γ, tumour necrosis factor-α, lymphotoxin and IL-2 receptor by Fip-o was also demonstrated by reverse transcriptase-PCR. This finding suggests that Fip-o exerts its immunomodulatory effects via cytokine regulation. In addition, the complete amino acid sequence of Fip-o was obtained by direct protein sequencing. This protein consists of 112 amino acid residues with a blocked N-terminal end and has a calculated molecular mass of 12 667 Da not including the N-terminal blocking group. By gel filtration analysis, Fip-o exhibited a molecular mass of 26 kDa for the native molecules in PBS. This result indicates that native Fip-o is most likely a non-covalently associated homodimeric molecule.
investigating their effects on systemic anaphylaxis and Arthus reaction in mice. Treatment of mice with Fips efficiently suppressed BSA-induced systemic anaphylaxis. Evidence that Fips suppress antibody production came from the result that the proportion of Arthus reaction-positive mice was reduced to 40 % by LZ-8. Co-incubation of mouse spleen cells or human PBL with Fips resulted in enhanced production of cytokines including interleukin (IL)-2, interferon-γ (IFN-γ) and tumour necrosis factor-α (TNF-α) when analysed by ELISA or reverse transcriptase (RT)-PCR [1, 3] . In addition, LZ-8 was able to prevent the occurrence of autoimmune diabetes in young female nonobese diabetes mice [4] and to delay the rejection process of transplanted allogeneic pancreatic rat islets and allografted mouse skin [5] . Fip-f e and LZ-8 consist of 114 and 110 amino acid residues respectively [1, 6] . Alignment of the two Fips shows 63.6 % identity. In the present study, a new Fip, Fip-o, was purified from the fruit bodies of Vol ariella ol acea, and its biochemical characteristics and biological activities were studied. To further characterize this protein, the complete amino acid sequence of Fip-o was determined and compared with that of other fungal immunomodulatory proteins.
EXPERIMENTAL Materials
Grass mushroom, V. ol acea, was obtained from the local market. DE-52 cellulose and CM-52 cellulose were purchased from Whatman (Maidstone, Kent, U.K. 
Purification of Fip-vvo
All purification steps were carried out at 4 mC. Fresh fruit bodies of V. ol acea (3 kg) were homogenized with 3 litres of 5 % (v\v) acetic acid in the presence of 0.1 % (v\v) 2-mercaptoethanol. The homogenates were centrifuged at 10 000 g for 20 min in a Beckman JA-14 rotor and soluble proteins in the supernatant were precipitated by addition of ammonium sulphate to 95 % saturation. After stirring for 1 h, the precipitates were collected by centrifugation at 20 000 g in a Beckman JA-20 rotor for 30 min. The pellets were dialysed against 5 litres of 10 mM sodium phosphate buffer, pH 8.2, for 48 h with four changes of dialysis solution. The dialysate was first fractionated on a Whatman DE-52 cellulose column (2.5 cmi20 cm) which was pre-equilibrated with 10 mM sodium phosphate buffer, pH 8.2. The activity was monitored by blast-formation stimulatory activity and haemagglutination test, and the flow-through fractions were found to be active. The active fractions were pooled and applied to a Whatman CM-52 cellulose column (2.5 cmi20 cm) that was previously equilibrated with 10 mM sodium acetate, pH 4.8. The column was first washed with 200 ml of equilibrium buffer (10 mM sodium acetate, pH 4.8), then eluted with a linear gradient of NaCl (0-0.25 M over 1 litre) in 10 mM sodium acetate, pH 4.8. The active fractions eluted from the CM-52 cellulose column were combined and further purified on a Mono S HR 5\5 column that was pre-equilibrated with 10 mM sodium acetate, pH 5.2. After washing the column with 7 ml of the same buffer, Fip-o was eluted with 15 ml of 0-0.075 M NaCl in 10 mM sodium acetate, pH 5.2.
Haemagglutination assay
Haemagglutination activity was measured as described previously [7] . Fresh blood was obtained from male animals housed in a specific pyrogen-free room. Blood for monitoring haem- agglutination activity was from Wistar rats. After washing the whole blood with PBS three times, blood cells were collected by centrifugation at 300 g for 10 min and then suspended to 1.5 % (v\v) with PBS. Various fractions (0.1 ml) from each purification step and 1.5 % blood (0.1 ml) were placed in 96-well U-bottom microtitre plates and incubated at room temperature. The plates were examined for haemagglutination after 2 h.
SDS/PAGE
Active fractions isolated from each purification step were subjected to SDS\PAGE analysis for detection of the purity. SDS\PAGE (12.5 %, w\v) was performed on a Bio-Rad mini protein II gel apparatus according to the method of Laemmli [8] . The gels were visualized by staining with Coomassie Brilliant Blue R-250 or by periodic acid\Schiff technique to detect the carbohydrate content [9] .
Blast-formation stimulatory activity assay
Heparinized human peripheral blood was centrifuged over a Ficoll-Paque isopycnic gradient to isolate lymphocytes. The cells were resuspended in RPMI 1640 medium supplemented with 15 % (v\v) fetal calf serum, 100 µg\ml streptomycin, 100 units\ml penicillin, 10 mmol\l Hepes, pH 7.3, and 200 mmol\l -glutamate [10] and the cell number was adjusted to 5i10' cells\ml. The cell suspension was seeded in a 96-well microtitre plate (0.1 ml, 5i10& cells\well) and various concentrations of Fip-o, PHA or Fip-o and PHA in 0.1 ml of PBS were added to the wells. After incubation of the cells at 37 mC under 5 % CO # in air for 42 h, 10 µl of [$H]thymidine (0.25 µCi, Amersham) was added and the cells were further incubated for 6 h under the same conditions. The cells were harvested with an automated cell harvester onto a glass filter, and the radioactivity of each sample was determined with a Beckman model LS 250 scintillation counter. Each reported value was the mean of triplicate samples.
RNA extraction and RT-PCR
Three Balb\c mice (5-8 weeks old) were killed by cervical dislocation and the spleens were removed by sterile technique. Spleen cells were isolated by centrifugation over an IsopaqueFicoll mixture and then resuspended in RPMI 1640 medium supplemented with 10 % fetal calf serum, 100 µg\ml streptomycin, 100 units\ml penicillin, 10 mmol\l Hepes, pH 7.3, and 200 mmol\l -glutamate, at 5i10' cells\60-mm Petri dish. The cultures were treated with various concentrations of Fip-o at 37 mC under 5 % CO # in air for 4 h. Total cellular RNAs were isolated by the acid guanidinium\thiocyanate\phenol\chloro-form method [11] . Random hexamer-primed cDNAs were prepared in a 20 µl volume from 1 µg of total RNA using MMLV reverse transcriptase under conditions recommended by the manufacturer. The primers used to amplify the cDNA fragments of specific cytokines for analysis of gene expression were : IL-1α forward, 5h-CTCTAGAGCACCATGCTACAGAC-3h, IL-1α reverse 5h-TGGAATCCAGGGGAAACACTG-3h, IL-2 forward 5h-TTCAAGCTCCACTTCAAGCTCTACAGCGGA-AG-3h, IL-2 reverse 5h-GACAGAAGGCTATCCATCTCCTC-AGAAAGTCC-3h, IL-3 forward 5h-GAAGTGGATCCTGAG-GACAGATACG-3h, IL-3 reverse 5h-GACCATGGGCCATG-AGGAACATTC-3h, IL-4 forward 5h-ATGGGTCTCAACCCC-CAGCTAGT-3h, IL-4 reverse 5h-GCTCTTTAGGCTTTCCAG-GAAGTC-3h, IL-5 forward 5h-ATGACTGTGCCTCTGTGCC-TGGAGC-3h, IL-5 reverse 5h-CTGTTTTTCCTGGAGTAAA-CTGGGG-3h, IL-6 forward 5h-TGGAGTCACAGAAGGAG-TGGCTAAG-3h, IL-6 reverse 5h-TCTGACCACAGTGAGGA-ATGTCCAC-3h, IFN-γ forward 5h-TGAACGCTACACACTG-CATCTTGG-3h, IFN-γ reverse 5h-CGACTCCTTTTCCGCTT-CCTGAG-3h, TNF-α forward 5h-ATGAGCACAGAAAGCA-TGATCCGC-3h, TNF-α reverse 5h-CCAAAGTAGACCTGC-CCGGACTC-3h, lymphotoxin (LT) forward 5h-TGGCTGGGA-ACAGGGGAAGGTTGAC-3h, LT reverse 5h-CGTGCTTTCT-TCTAGAACCCCTTGG-3h, IL-2 receptor (IL-2R) forward 5h-ACTGTGAATGCAAGAGAGGTTTCCG-3h, IL-2R reverse 5h-AGCAGGACCTCTCTGTAGAGCCTTG-3h [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . For internal control, β-actin was employed by using the primers : forward 5h-GTGGGCCGCTCTAGGCACCAA-3h, and reverse 5h-CTCTTTGATGTCACGCACGATTTC-3h [22] . PCR was carried out in a 50 µl mixture (20 mM Tris\HCl, pH 8.3, 2.5 mM MgCl # , 25 mM KCl, 0.05 % Tween 20, 100 µg\ml nuclease-free BSA, 200 µM each dNTP, 1 µl of first-strand cDNA template, 10 pmol of each primer, and 2 units of Taq DNA polymerase), and 30 cycles of exponential amplification were performed. The cycling parameters were as follows : 94 mC for 1 min (5 min before the first cycle), 60 mC for 1 min (65 mC for IL-2 primers), 72 mC for 2 min, with an additional 7 min final extension at 72 mC. The amplified products were analysed by 1.5 % (w\v) agarose gel electrophoresis.
Immunomodulatory activity assay

Systemic anaphylaxis reaction
Male Balb\c mice (5 weeks old, body weight 17-20 g) were sensitized by intraperitoneal or subcutaneous injection with 1 mg of BSA in 0.2 ml of aluminium hydroxide suspension (15 mg\ml) at day 0 and were shocked by intravenous injection with 1 mg of BSA in 0.2 ml of PBS at day 17. For negative control, 1 mg of ovalbumin in 0.2 ml of PBS was injected instead of BSA at the time of the shocking injection. To examine the immunomodulatory activity of Fip-o, mice in the experimental group were intraperitoneally injected with 7.5 mg of Fip-o\kg body weight twice a week for a total of seven times including two injections before BSA sensitization. In experiment 2, mice in one experimental group received the shocking injection combined with 150 µg of Fip-o and 1 mg of BSA in 0.2 ml of PBS at day 17. The systemic anaphylaxis reaction was observed within 30 min after the shocking injection and rated in the following way : positive reaction, mouse died or rendered stationary for at least 1 min ; negative reaction, no changes were observed and movement remained normal.
Arthus reaction
Twenty male Balb\c mice (body weight 17-20 g) were sensitized with 1 mg of BSA in 0.2 ml of aluminium hydroxide suspension (15 mg\ml) at day 0 and day 7 subcutaneously. Ten mice were treated with Fip-o (7.5 mg\kg body weight ; intraperitoneally) were administered seven times, at days k6, k3, 0, 3, 6, 9 and 12. At day 14, 20 µl of BSA (0.5 mg\ml in PBS) was injected intradermally into the left footpad of each mouse and 20 µl of PBS was injected into each right footpad as a control. The thicknesses of footpads were measured at least six times with a digital-type measure at 2 h, 1 day, 2 days and 3 days after injection of BSA and PBS. After discarding the extreme values, the difference between left and right footpads was calculated by a statistical method. The mice with positive reaction were defined as those differing at P 0.05.
Amino acid analysis
Protein concentration was determined by the bicinchoninic acid method [23] . Samples for amino acid analysis were hydrolysed with 6 M HCl for 24, 48 and 72 h at 110 mC. After removal of HCl, the hydrolysate was dissolved in Beckman Na-S buffer, pH 2.0, and applied to an automatic Beckman 6300 system amino acid analyser. Values for threonine and serine were corrected for hydrolysis loss by extrapolating to zero time relative to alanine. Tryptophan content was measured from spectroscopic absorbance at 280 and 288 nm in 6 M guanidine\HCl by the method of Edelhoch [24] .
Enzymic cleavage of Fip-vvo
For proteolytic peptide mapping, approx. 500 µg of Fip-o was dried in a Speed-Vac and digested with trypsin, lysyl-C endopeptidase, chymotrypsin and thermolysin. The enzyme\substrate ratio was 1 : 50. Tryptic, chymotryptic or thermolytic digestion was carried out in 50 mM ammonium bicarbonate, pH 8.0, at 37 mC for 18 h, and lysyl-C endopeptidase digestion was performed in 50 mM Tris\HCl, pH 9.0, at 37 mC for 18 h [25] . 
Fractionation of peptides and sequence analysis
The peptides generated by various enzymic digestions were fractionated by reversed-phase HPLC on a Beckman C-18 column (4.6 mmi10 cm) or Vydac C-18 column (4.6 mmi25 cm) using a linear gradient of 10-65 % (v\v) acetonitrile containing 0.07 % (v\v) trifluoroacetic acid over 30 min at a flow rate of 1 ml\min. Some peaks were further purified on a Beckman C-8 column (4.6 mmi25 cm). The peptides were collected by monitoring at 215 nm and dried under vacuum, then the purified peptides were subjected to amino acid sequence analysis using an Applied Biosystems 470A protein sequencer.
RESULTS AND DISCUSSION
Purification of Fip-vvo
Assay of Fip-vvo
The assay procedure for Fip-o was described in the Experimental section and used in the chromatographic purification of the protein. The assay was not applicable to crude preparations of V. ol acea such as the ammonium sulphate fraction (Table 1) , which contained substances causing cell lysis in the haemagglutination and the blast-formation stimulatory assay.
Purification of Fip-vvo
The purification procedure for Fip-o consisted of ammonium sulphate precipitation, column chromatography on DE-52 cellulose, CM-52 cellulose, and Mono S. Elution profiles of proteins are shown in Figure 1 . DE-52 cellulose column chromatography gave four elution peaks absorbing at 280 nm. The first three peaks were eluted by 10 mM sodium phosphate buffer, pH 8.2, and the fourth peak was eluted by 0.1 M NaCl in the same buffer. Highest specific activity was observed in peak 1 by haemagglut- ination and blast-formation stimulatory activity assay. The active fractions were collected for further purification by CM-52 cellulose column chromatography and two major absorption peaks were obtained. The second peak eluted with a linear gradient of NaCl (0-0.25 M in 10 mM sodium acetate, pH 4.8) exhibited the haemagglutination and mitogenic activities, and showed minor contamination of other proteins by SDS\PAGE analysis. Using Mono-S cation exchange FPLC, Fip-o was eluted with a linear gradient of NaCl (0-0.075 M) in a total volume of 15 ml of 10 mM sodium acetate, pH 5.2. After three chromatographic steps, 115 mg of Fip-o was normally obtained from 3 kg of fresh fruit bodies. As the specific activity could not be quantified in the ammonium sulphate fraction, the yield of Fip-o in the first step could not be calculated (Table 1 ). In the haemagglutination assay using rat red blood cells, the fraction purified from CM-52 cellulose column chromatography showed higher total activity than that isolated from DE-52 column 
Figure 4 Effects of Fip-vvo on the expression of (A) IL-2, (B) IL-4, (C) IFN-γ, (D) TNF-α, (E) LT and (F) IL-2R genes in mouse spleen lymphocytes
Gene expression was analysed by RT-PCR. The equivalent of 1 µg of total RNA extracted from the mouse spleen cells incubated with various concentrations of Fip-vvo was reverse transcribed and amplified under the conditions specified. The amplified fragments and β-actin-specific fragments are shown as visualized by ethidium bromide staining. M, bp DNA (100-1000 bp).
chromatography. However, the assay measuring blast-formation stimulatory activity of human PBL gave a purification of 4.2-fold after CM-52 ion-exchange chromatography and a final recovery of 53 %. From these results it was suggested that the DE-52 column chromatography purified fraction contained substances that were capable of inhibiting the haemagglutination activity.
Homogeneity of Fip-vvo
Following each purification step, SDS\PAGE was used to examine the homogeneity of Fip-o. Purified Fip-o migrated as a single band to the position corresponding to that of the 15-kDa polypeptide (Figure 2) . By staining the polyacrylamide gel with periodic acid\Schiff reagent, Fip-o showed negative
Figure 5 Reversed-phase HPLC of (A) chymotrypsin digest of Fip-vvo, (B) lysyl endopeptidase digest of Fip-vvo, (C) trypsin digest of Fip-vvo, (D) thermolysin digest of Fip-vvo on a Beckman C-18 column
The details are described in the Experimental section.
staining. These observations indicated that Fip-o is a single protein with very low or no carbohydrate content. The amino acid composition of Fip-o is presented in Table 2 . Halfcysteine, methionine, histidine and hydroxyproline were not detected. The results of amino acid analysis reveal that Fip-o comprises large amounts of asparagine or aspartic acid. In addition, Fip-o has a higher number of lysine residues than of arginine residues, which is one of the properties of Fips.
Blast-formation stimulatory activity assay
Preliminary experiments were performed on human PBL using different doses of Fip-o. At 1-5 µg\ml, weak thymidine uptake was elicited by Fip-o after 24 h incubation ; however, a substantial response was observed at 48 h. Thus for the blastformation stimulatory activity assay, a 48-h incubation period was used. As shown in Figure 3 , Fip-o induced the proliferation of human PBL in a dose-dependent manner. The concentration of Fip-o giving the optimal thymidine uptake was 5 µg\ml, which was similar to the optimal concentration of PHA. When Fip-o and PHA were incubated together, the maximum uptake of [$H]thymidine was shifted to 5 µg\ml total mitogens or 2.5 µg\ml each. Analysis of the proliferation curve showed that previously ; however, Fip-o was 20-fold more potent than Fipf e on lymphocyte activation. The effect of carbohydrates on the blast-formation stimulatory activity of Fip-o was also examined. In the presence of 0-50 mM galactose, glucose, mannose, α-methyl--mannoside, fucose, fructose, N-acetylgalactosamine, N-acetylglucosamine, 1-Omethyl α--glucopyranoside, lactose or sucrose, no inhibition of lymphocyte proliferation was observed at 5 µg\ml Fip-o.
Hemagglutination reaction
Using red blood cells from various species, the haemagglutination activity of Fip-o was examined. Fip-o was able to agglutinate red blood cells of Wistar rats at concentrations greater than 0.52 µg\ml. With red blood cells from Balb\c mice and rabbits, the minimal concentration of Fip-o required for haemagglutination was 1.1 µg\ml and 0.13 µg\ml respectively. The aggregation of human red blood cells of all four types (A, B, AB and O) in the presence of Fip-o was not seen when the concentration was raised to 175 µg\ml. This result was consistent with the low haemagglutination activity of LZ-8 towards human red blood cells, whereas Fip-f e aggregates human red blood cells efficiently.
The sugar specificity of Fip-o was determined with a series of sugars (galactose, glucose, mannose, α-methyl -mannoside, fructose, fucose, N-acetylglucosamine, N-acetylgalactosamine, glucosamine, galactosamine, 1-O-methyl α--glucopyranoside, 1-O-methyl α--galactopyranoside, N-acetylneuraminic acid, lactose and sucrose) all at a final concentration of 100 mM (5 mM for N-acetylneuraminic acid) . None of the sugars studied was found to have inhibitory effects on the haemagglutination activity using rat red blood cells. Goldstein et al. [26] have defined a lectin as a sugar-binding protein or glycoprotein that agglutinates cells and\or precipitates glycoconjugates. The specificity of a lectin is usually defined in terms of the monosaccharides or oligosaccharides that inhibit lectin-induced agglutination reactions. From the haemagglutination and cell proliferation assays, Fip-o exhibited the major biological activities of lectins. However, the sugar specificity of Fip-o could not be determined by using mono-and disaccharides in these experiments. It is known that the monosaccharide residue in a terminal non-reducing position on a glycan is not the only carbohydrate moiety recognized by a lectin [27] . Fip-o may specifically recognize a more complex oligosaccharide chain on a glycan instead of the monosaccharide at the terminus.
Immunomodulatory activity assay
The immunomodulatory activity of Fip-o was explored by examining its effects on systemic anaphylaxis and Arthus reaction in Balb\c mice. Table 3 shows the effects of Fip-o on the production of systemic anaphylaxis. All the mice in the positive control group sensitized with BSA in aluminium adjuvant subcutaneously (Experiment 1) or intraperitoneally (Experiment 2) at day 0, then shocked with BSA in PBS at day 17, displayed symptoms of systemic anaphylactic shock. As a negative control, BSA in the shocking injection was replaced with ovalbumin and the mice showed no anaphylactic reaction. After administration of Fip-o seven times, including two injections before BSA sensitization, there were fewer mice with systemic anaphylaxis than in the positive control group both in Experiment 1 (7\10) and in Experiment 2 (6\10). However, when compared with other Fips (Fip-f e and LZ-8), Fip-o exhibited less potency in the prevention of systemic anaphylaxis. The immediate effect of Fip-o on anaphylactic shock was not seen when 150 µg of Fipo was injected in combination with BSA in the shocking injection (Experiment 2).
The effect of Fip-o on Arthus reaction is shown in Table 4 . All the mice in the control group displayed positive footpad reactions within 2 h. However, only 40 % displayed positive footpad reactions to BSA for mice administered with Fip-o twice a week. Statistical analysis showed that the comparison of two proportions of positive reactions was significant (P 0.05). The footpad thicknesses were also measured at 2 and 3 days ; no difference was observed between the control and the Fip-otreated groups. This ensured that the swelling of the footpad was not caused by a cell-mediated delayed-type reaction.
The Arthus reaction is a dermal inflammatory response caused by the reaction of precipitating antibody with antigen placed in the skin. The deposition of immune complex results in activation of complement and subsequent neutrophil infiltration. Despite it not being clear how Fip-o exerts it effect on reduction of Arthus reaction, the immunomodulatory action of Fip-o is evident from this study.
The immunomodulatory activities of Fip-o in itro were investigated by examining the induction of cytokine gene expression. Mouse spleen cells were cultured with various concentrations of Fip-o for 4 h and the total RNAs were prepared for subsequent RT-PCR analysis. After converting the RNAs to single strand cDNA, the transcripts of the genes encoding IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, TNF-α, IFN-γ, LT and IL-2R were analysed by PCR using specific primers described in the Experimental section. As shown in Figure 4 
Complete amino acid sequence of Fip-vvo
The complete primary structure of Fip-o was determined by sequencing the peptides generated by chymotrypsin, lysyl endopeptidase, trypsin and thermolysin digestion. After enzymic cleavage the resulting peptides were purified by reversed-phase HPLC and subsequently analysed by automated protein sequencing ( Figure 5 ). C10 ( Figure 5A ) and The10 ( Figure 5D ) were further purified on a Beckman C-8 column. The N-terminal end of native Fip-o was blocked. By treating native Fip-o or N-terminal peptide (C-19) with 100 % trifluoroacetic acid at 70 mC for 30 min, the N-terminal blocking group was removed and the deblocked products were then subjected to amino acid sequencing. Figure 6 shows the complete amino acid sequence of Fip-o together with sequencing strategy. This protein is composed of 112 amino acid residues and its calculated molecular mass is 12 667 Da not including the N-terminal blocking residue. To identify the N-terminal blocking acyl group, the molecular mass of native Fip-o was measured by matrix-assisted-laserdesorption\ionization time-of-flight mass spectrometry in a Bruker Biflex system and a molecule mass m\z 12 711 was obtained. This mass is 44 Da greater than the theoretical mass calculated from the sequence data. It is most likely that the N-terminal blocking group is an acetyl group with a molecular mass of 43 Da. By gel filtration FPLC on a Superose 12 column, Fip-o exhibited a molecular mass of 26 kDa for the native molecules in PBS. This result indicates that native Fip-o is most likely a non-covalently associated homodimeric protein that functions divalently (or multivalently) in cell aggregation and activation.
Analysis of the primary structure of Fip-o reveals that there is no consensus sequence (Asn-Xaa-Ser or Thr) as an attachment site for an Asn-linked oligosaccharide chain, which is compatible with the negative results of periodic acid\Schiff staining of SDS\PAGE. In addition, Fip-o contains one potential casein kinase II phosphorylation site at Ser$$-Tyr-Ile-Asp and three potential protein kinase C phosphorylation sites at Thr%&-AsnLys, Ser($-Gln-Lys and Thr*#-Ile-Lys [29, 30] . The involvement of
